echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Six new chinese medicines, ginseng pills, have been approved for clinical trials to treat spinal-type cervical vertebral disease.

    Six new chinese medicines, ginseng pills, have been approved for clinical trials to treat spinal-type cervical vertebral disease.

    • Last Update: 2020-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Cervical vertebral disease can be divided into cervical type, nerve root type, spinal cord type, other type (vertebral artery type, sympathetic type).
    spinal spinal cervical vertebral disease (Cervical spondylotic myelopathy, CSM) refers to cervical vertebral disease sepsis, which is the basis of cervical vertebral small joints and intervertebral disc retreats into the basic pathological basis, and which suppresses the spinal cord or the blood vessels that govern the spinal cord, causing the section of the vertebral tube cavity stenosis and causing chronic compression or (and) spinal cord blood supply disorders of the spinal cord and causing spinal cord dysfunction.
    at present, the treatment of clinical CSM is still lacking drugs that can effectively control its development and promote the patient's functional recovery.
    nonsteroidal anti-inflammatory drugs, glucocorticoids, neurotrophic drugs, surgical intervention is a modern medical CSM conventional treatment method.
    the purpose of drug therapy is to control the patient's pain, numbness and other symptoms, and lack of the role of neuropathy. Although the effect of
    surgery is more accurate on CSM, there are also deficiencies such as higher postoperative complications and poor functional recovery after reduction of stress.
    for the above reasons, seeking further effective and safe intervention of CSM, and the rapid application of clinical treatment methods is the focus of drug research and development.
    May 2015, Shanghai and Huang Pharmaceutical Co., Ltd. and Longhua Hospital, affiliated with Shanghai University of Traditional Chinese Medicine, jointly developed six new chinese medicine class ginseng pills.
    the clinical value of the development of the new drug lies in the early and medium prevention of spinal cervical vertebral disease and later with surgical treatment to solve local inflammation, ischemia or hemostatic stimulation caused by the continued damage of the spinal cord and other problems, improve clinical efficacy, can fill the current clinical treatment of spinal cervical vertebral disease blank, has important development value and clinical significance.
    original title: and Huang Pharmaceuticalco hand in hand with Longhua Hospital: Chinese medicine 6 new drugs ginseng pills approved for clinical trial.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.